Literature DB >> 75252

[Age, duration of disease and survival period of patients with involvement of the nervous system by malignant lymphomas. A statistical comparison of mycosis fungoides with lymphogranulomatosis (author's transl)].

H Heintel, U Heintel-Tröster.   

Abstract

A statistical comparison dealing with age, duration of disease and survival period of patients with involvement of the nervous system by malignant lymphomas revealed the following data: 1. With mycosis fungoides, involvement of the nervous system occurs later in life than with lymphogranulomatosis; this difference is statistically highly significant (P less than 0.001). 2. There is no statistical difference (P greater than 0.05) in the duration of either type of malignant lymphoma before the nervous system becomes involved. 3. It is of high statistical significance (P less than 0.001) that, once the nervous system has become involved, the survival period is lower with mycosis fungoides than with lymphogranulomatosis. It can be expected that involvement of the nervous system by mycosis fungoides leads with 79% probability (confidential limits 99% = 47.29--96.22%) to death within 6 months.

Entities:  

Mesh:

Year:  1977        PMID: 75252     DOI: 10.1007/BF00316316

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  10 in total

1.  [NEUROLOGICAL SYMPTOMS IN HODGKIN'S DISEASE].

Authors:  A HAYNAL; F REGLI
Journal:  Schweiz Med Wochenschr       Date:  1964-10-24

2.  [Neurological complications of malignant lymphogranulomatosis].

Authors:  H THIES; H KIEFER; H NOETZEL
Journal:  Dtsch Med Wochenschr       Date:  1961-10-06       Impact factor: 0.628

3.  Mycosis fungoides followed for fourteen years; the case of Dr. W. B. Cannon.

Authors:  J C AUB; S B WOLBACH; B J KENNEDY; O T BAILEY
Journal:  AMA Arch Pathol       Date:  1955-11

4.  [Analysis of symptom frequency in mycosis fungoides].

Authors:  H J HEITE; P SOCHA
Journal:  Arch Dermatol Syph       Date:  1951

5.  [Meningocerebral manifestation of mycosis fungoides (author's transl)].

Authors:  P Engelhardt; R Richter
Journal:  Z Neurol       Date:  1973-12-11

6.  Central nervous system involvement by mycosis fungoides.

Authors:  J Rosai; J M Spiro
Journal:  Acta Derm Venereol       Date:  1968       Impact factor: 4.437

7.  Mycosis fungoides and progressive multifocal leukoencephalopathy.

Authors:  I Caldwell; A D Dayan
Journal:  Br J Dermatol       Date:  1970-02       Impact factor: 9.302

8.  [Mycosis fungoides with involvement of leptomeninges, cranial and spinal nerves, and spinal ganglia: "meningeosis mycoides fungosa"].

Authors:  H Heintel; U Heintel-Tröster; C Worbes
Journal:  Dtsch Z Nervenheilkd       Date:  1969

9.  Mycosis fungoides involving the brain.

Authors:  M B Weber; M H McGavran
Journal:  Arch Neurol       Date:  1967-06

10.  [Cerebral involvement in the Sézary syndrome (author's transl)].

Authors:  F Gerstenbrand; K Jellinger; D Lutz; E Maida
Journal:  J Neurol       Date:  1976-03-23       Impact factor: 4.849

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.